Annual Long Term Debt
$65.76 M
-$14.41 M-17.97%
31 December 2023
Summary:
C4 Therapeutics annual long term debt is currently $65.76 million, with the most recent change of -$14.41 million (-17.97%) on 31 December 2023. During the last 3 years, it has risen by +$43.88 million (+200.56%). CCCC annual long term debt is now -17.97% below its all-time high of $80.17 million, reached on 31 December 2022.CCCC Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$61.46 M
-$1.46 M-2.32%
30 September 2024
Summary:
C4 Therapeutics quarterly long term debt is currently $61.46 million, with the most recent change of -$1.46 million (-2.32%) on 30 September 2024. Over the past year, it has dropped by -$5.63 million (-8.39%). CCCC quarterly long term debt is now -27.65% below its all-time high of $84.95 million, reached on 31 March 2022.CCCC Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | -8.4% |
| 3 y3 years | +200.6% | +185.8% |
| 5 y5 years | +378.3% | - |
CCCC Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.0% | +200.6% | -27.6% | +185.8% |
| 5 y | 5 years | -18.0% | +411.0% | -27.6% | +377.6% |
| alltime | all time | -18.0% | +411.0% | -27.6% | +377.6% |
C4 Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $61.46 M(-2.3%) |
| June 2024 | - | $62.92 M(-2.2%) |
| Mar 2024 | - | $64.36 M(-2.1%) |
| Dec 2023 | $65.76 M(-18.0%) | $65.76 M(-2.0%) |
| Sept 2023 | - | $67.09 M(-1.9%) |
| June 2023 | - | $68.42 M(-12.7%) |
| Mar 2023 | - | $78.34 M(-2.3%) |
| Dec 2022 | $80.17 M | $80.17 M(-1.3%) |
| Sept 2022 | - | $81.23 M(-3.0%) |
| June 2022 | - | $83.74 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $84.95 M(+104.5%) |
| Dec 2021 | $41.55 M(+89.9%) | $41.55 M(+93.2%) |
| Sept 2021 | - | $21.51 M(-0.6%) |
| June 2021 | - | $21.64 M(-0.6%) |
| Mar 2021 | - | $21.76 M(-0.5%) |
| Dec 2020 | $21.88 M(+70.0%) | $21.88 M(-0.4%) |
| Sept 2020 | - | $21.97 M(-0.3%) |
| June 2020 | - | $22.04 M(+71.2%) |
| Dec 2019 | $12.87 M(-6.4%) | $12.87 M |
| Dec 2018 | $13.75 M | - |
FAQ
- What is C4 Therapeutics annual long term debt?
- What is the all time high annual long term debt for C4 Therapeutics?
- What is C4 Therapeutics annual long term debt year-on-year change?
- What is C4 Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for C4 Therapeutics?
- What is C4 Therapeutics quarterly long term debt year-on-year change?
What is C4 Therapeutics annual long term debt?
The current annual long term debt of CCCC is $65.76 M
What is the all time high annual long term debt for C4 Therapeutics?
C4 Therapeutics all-time high annual long term debt is $80.17 M
What is C4 Therapeutics annual long term debt year-on-year change?
Over the past year, CCCC annual long term debt has changed by -$14.41 M (-17.97%)
What is C4 Therapeutics quarterly long term debt?
The current quarterly long term debt of CCCC is $61.46 M
What is the all time high quarterly long term debt for C4 Therapeutics?
C4 Therapeutics all-time high quarterly long term debt is $84.95 M
What is C4 Therapeutics quarterly long term debt year-on-year change?
Over the past year, CCCC quarterly long term debt has changed by -$5.63 M (-8.39%)